How often does Idexx Laboratories move more than the options market prices?

5 of the last 8 reports moved at least as far as the implied move.

IDXXNasdaqIn Vitro & In Vivo Diagnostic Substances

Idexx Laboratories Inc (IDXX) earnings date, market-implied expected move, and options open interest by expiry

672.00

+0.36 · +0.05%

post 669.10 −0.43%

Closed19:37 ET

Open674.32Volume1.2MMkt cap$52.9BP/E44.88EPS14.91

Day663.12 – 680.4435%52-wk500.61 – 769.9863%

IDXX

Idexx Laboratories Inc

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Feb 1

before open · in 90 days

est.Q4 FY26

Calendar

Next report

Last report

+21.85%

vs ±8.6% implied · ×2.53

shaded = implied · ▲▼ = realized

Nov 2 '26 · confirmed

Implied vs realized

Linked news

7dVNRX · supplierVolitionRx prepays $500,000 on convertible note, balance $706,667; conversion paused

News

Largest filed tie

13F top-10 QoQ

+6.43%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

1,303 managers

Top fund weight

0.72%

IDXX weight · XLV

N-PORTJun 30 '26

10 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Idexx Laboratories (IDXX) is expected to report on Feb 1 before open (estimated date).

Implied vs realized

8 reports

5 of 8≥ implied

avg implied: ±7.9%
avg realized: ±11.6%

Feb 3 '25Feb 3 '25confirmed±7.2%▲+11.13%×1.54

May 1 '25May 1 '25confirmed±6.5%▲+8.95%×1.37

Aug 4 '25Aug 4 '25confirmed±6.9%▲+27.49%×4.01

Nov 3 '25Nov 3 '25confirmed±8.5%▲+14.84%×1.75

Feb 2 '26Feb 2 '26confirmed±8.9%▼−4.60%×0.51

Q1 FY26May 5 '26confirmed±8.0%▼−0.03%×0.00

Q2 FY26Aug 4 '26confirmed±8.4%▲+3.57%×0.42

Q3 FY26Nov 2 '26confirmed±8.6%▲+21.85%×2.53

quarterimplied−30%0+30%realized×

Q3 FY26±8.6%▲+21.85%×2.53

Q2 FY26±8.4%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 2 close

0.14OI · 4 expiries · Nov 2 closeP/C open interest · Apr 16 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

967+105%Nov 2017d3.79255+21%3.79

625+131%Dec 1845d0.91689+86%0.91

166+3%Jan 1573d0.285850%0.28

report · Feb 1 · before open · est.

72+3%Apr 16164d502+1%

ExpiryPutsCallsP/C

Nov 2017d967+105%255+21%3.79

Dec 1845d625+131%689+86%0.91

Jan 1573d166+3%5850%0.28

report · Feb 1 · before open · est.

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ3 FY26

26.12%as filednet margin · revenue −0.19% QoQ · +9.86% YoY

Revenue

$1.2B−0.19% QoQ

Gross profit

$764M−1.90% QoQ

62.94% margin

Operating income

$402M−5.46% QoQ

33.14% margin

Pre-tax income

$399M−4.29% QoQ

Net income

$317M−6.28% QoQ

26.12% margin

Cost of revenue

$450M+2.84% QoQ

Operating expenses

$362M+2.38% QoQ

Marketing $170M

SG&A $123M

R&D $69M

Other expense

$3M

Tax

$82M+4.27% QoQ

Revenue$1.2B−0.19%

Gross profit

$764M−1.90%

62.94% margin

Operating income

$402M−5.46%

33.14% margin

Pre-tax income

$399M−4.29%

Net income

$317M−6.28%

26.12% margin

Cost of revenue

$450M+2.84%

Operating expenses

$362M+2.38%

Marketing $170M

SG&A $123M

R&D $69M

Other expense

$3M

Tax$82M+4.27%

flow · deduction · signed % = QoQSource: SEC filings · standardized · QE Sep 30 '26 · width = $

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ down · bars = volume, 15mSource: market data · 19:30 ET

Intraday

Event sensitivity

CPI ×1.38· ±1.9% vs ±1.4% · 10 releases

eventrelease day|move|up · n×base

CPIconsumer prices±1.9%4 of 10×1.38

FOMCrate decision±1.5%10 of 24×1.06

PCEpersonal income & outlays±1.4%9 of 19×1.01

GDPgross domestic product±1.3%10 of 19×0.96

CPROFcorporate profits±1.3%6 of 12×0.96

PPIproducer prices±1.2%3 of 10×0.86

NFPjobs report±1.1%5 of 10×0.82

Bar = avg |move| to ±2% · tick = ±1.4% avg day · ×base = |move| ÷ ±1.4% · min 6 releases

Earnings history

EPS 4.01 · consensus —

Quarter	Reported	EPS	Consensus
Q3 FY26	Nov 2 '26 · confirmed	4.01	—
Q2 FY26	Aug 4 '26 · confirmed	4.27	—
Q1 FY26	May 5 '26 · confirmed	3.47	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod